bpc-157 human clinical trials safety fda status evidence Evidence out, ideology in. The FDA's quiet BPC-157 Before the FDA: Briefing

~ AlphaMD Let's address the elephant in the room, or rather, the thing that gets smaller in the room

Diabetic neuropathy can be asymptomatic in some patients, but it may manifest as paresthesias, burning sensations, and numbness in the feet

Sublingual administration, which bypasses the gastrointestinal tract, appears to be equally effective as IM injections while being less invasive and more cost-efficientparticularly in patients with atrophic gastritis, post-gastrectomy status, or conditions that impair intrinsic factor-mediated absorption, where long-term intervention is often required

In contrast, injections can show results in just a few days

medical supervision is advised